25 results on '"Zhang, Hongwei"'
Search Results
2. ROCK1 activation-mediated mitochondrial translocation of Drp1 and cofilin are required for arnidiol-induced mitochondrial fission and apoptosis
- Author
-
Hu, Jinjiao, Zhang, Hongwei, Li, Jie, Jiang, Xiuxing, Zhang, Yanhao, Wu, Qin, Shen, liwen, Shi, Jingshan, and Gao, Ning
- Published
- 2020
- Full Text
- View/download PDF
3. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine
- Author
-
Hu, Jinjiao, Zhang, Yanhao, Jiang, Xiuxing, Zhang, Hongwei, Gao, Ziyi, Li, Yunong, Fu, Ruoqiu, Li, Lirong, Li, Jie, Cui, Hongjuan, and Gao, Ning
- Published
- 2019
- Full Text
- View/download PDF
4. Oncolytic adenovirus-mediated short hairpin RNA targeting MYCN gene induces apoptosis by upregulating RKIP in neuroblastoma
- Author
-
Li, Yuan, Zhang, Hongwei, Zhu, Xiaoyu, Feng, Dongchuan, Zhang, Deyong, Zhuo, Baobiao, and Zheng, Junnian
- Published
- 2015
- Full Text
- View/download PDF
5. Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo
- Author
-
Zhuo, Baobiao, Wang, Rong, Yin, Yiyu, Zhang, Hongwei, Ma, Tongsheng, Liu, Fengli, Cao, Hui, and Shi, Yingchun
- Published
- 2013
- Full Text
- View/download PDF
6. Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- Author
-
Zhang, Hongwei, Li, Mengbin, Han, Yu, Hong, Liu, Gong, Taiqian, Sun, Li, and Zheng, Xiushan
- Published
- 2010
- Full Text
- View/download PDF
7. UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer.
- Author
-
Ding, Silu, Zhang, Hongwei, Zhao, Xinyu, Dang, Jun, and Li, Guang
- Abstract
UNC5A has been reported to be related with human cancers. However, the function and mechanism in non-small cell lung carcinoma (NSCLC) remains unknown. We analyzed two NSCLC cell lines (A549 and H157), one normal human bronchial epithelial cell line (BEAS-2B) and the tissues of NSCLC. We used quantitative real-time PCR (qRT-PCR), western blot and immunohistochemical (IHC) staining to examine the expression of UNC5A. Methylation status of the UNC5A promoter was analyzed using methylation-specific PCR (MSP) and bisulfite sequencing PCR (BSP). We used western blot to analyzed protein levels of PI3K/Akt pathway. We found that the mRNA expression of UNCA5 was significantly downregulated in NSCLC cells and tissues. The promoter of UNC5A was hypermethylated in NSCLC cells compared to normal control cells. The expression of UNC5A could be reversed by demethylation agent in NSCLC cells. The expression of UNC5A was decreased in NSCLC samples and significantly associated with the advanced types of NSCLC. Functionally, knockdown of UNC5A promoted cell proliferation, migration, invasion and induced apoptosis in NSCLC, overexpression of UNC5A yielded the opposite result. Moreover, we found that UNC5A negatively regulated PI3K/Akt signaling pathway in NSCLC. UNC5A is a novel epigenetically silenced gene in NSCLC and consequent under-expression of UNC5A may contribute to NSCLC tumorigenesis through regulating PI3K/Akt pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Reciprocal regulations between miRNAs and HIF-1α in human cancers.
- Author
-
Yang, Wanli, Ma, Jiaojiao, Zhou, Wei, Cao, Bo, Zhou, Xin, Zhang, Hongwei, Zhao, Qingchuan, Hong, Liu, and Fan, Daiming
- Subjects
HYPOXIA-inducible factor 1 ,CANCER invasiveness ,NON-coding RNA ,NEOPLASTIC cell transformation ,CANCER patients ,GENE regulatory networks - Abstract
Hypoxia inducible factor-1α (HIF-1α) is a central molecule involved in mediating cellular processes. Alterations of HIF-1α and hypoxically regulated microRNAs (miRNAs) are correlated with patients' outcome in various cancers, indicating their crucial roles on cancer development. Recently, an increasing number of studies have revealed the intricate regulations between miRNAs and HIF-1α in modulating a wide variety of processes, including proliferation, metastasis, apoptosis, and drug resistance, etc. miRNAs are a class of small noncoding RNAs which function as negative regulators by directly targeting mRNAs. Evidence shows that miRNAs can be regulated by HIF-1α at transcriptional level. In turn, HIF-1α itself can be modulated by many miRNAs whose alterations have been implicated in tumorigenesis, thus forming a reciprocal regulation network. These findings add a new layer of complexity to our understanding of HIF-1α regulatory networks. Here, we will provide a comprehensive overview of the current advances about the bidirectional interactions between HIF-1α and miRNAs in human cancers. Besides, the review will summarize the roles of miRNAs/HIF-1α crosstalk according to various cellular processes. Finally, the potential values of miRNAs/HIF-1α loops in clinical applications are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
- Author
-
Han, Qi, Chen, Rui, Wang, Fangjie, Chen, Sha, Sun, Xiongshan, Guan, Xiao, Yang, Yao, Peng, Bingjie, Pan, Xiaodong, Li, Jinfang, Yi, Weijing, Li, Peng, Zhang, Hongwei, Feng, Dongfang, Chen, An, Li, Xiaohui, Li, Shuhui, and Yin, Zuoming
- Subjects
ANTINEOPLASTIC agents ,BREAST cancer treatment ,FLUOROURACIL ,DRUG efficacy ,PROTEIN expression ,ELECTROMAGNETIC fields - Abstract
Resistance to 5-fluorouracil (5-FU) and its induced immune suppression have prevented its extensive application in the clinical treatment of breast cancer. In this study, the combined effect of 50 Hz-EMFs and 5-FU in the treatment of breast cancer was explored. MCF-7 and MCF10A cells were pre-exposed to 50 Hz-EMFs for 0, 2, 4, 8 and 12 h and then treated with different concentrations of 5-FU for 24 h; cell viability was analyzed by MTT assay and flow cytometry. After pre-exposure to 50 Hz-EMFs for 12 h, apoptosis and cell cycle distribution in MCF-7 and MCF10A cells were detected via flow cytometry and DNA synthesis was measured by EdU incorporation assay. Apoptosis-related and cell cycle-related gene and protein expression levels were monitored by qPCR and western blotting. Pre-exposure to 50 Hz-EMFs for 12 h enhanced the antiproliferative effect of 5-FU in breast cancer cell line MCF-7 in a dose-dependent manner but not in normal human breast epithelial cell line MCF10A. Exposure to 50 Hz-EMFs had no effect on apoptosis and P53 expression of MCF-7 and MCF10A cells, whereas it promoted DNA synthesis, induced entry of MCF-7 cells into the S phase of cell cycle, and upregulated the expression levels of cell cycle-related proteins Cyclin D1 and Cyclin E. Considering the pharmacological mechanisms of 5-FU in specifically disrupting DNA synthesis, this enhanced inhibitory effect might have resulted from the specific sensitivity of MCF7 cells in active S phase to 5-FU. Our findings demonstrate the enhanced cytotoxic activity of 5-FU on MCF7 cells through promoting entry into the S phase of the cell cycle via exposure to 50 Hz-EMFs, which provides a novel method of cancer treatment based on the combinatorial use of 50 Hz-EMFs and chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Hypocrellin B in hepatocellular carcinoma cells: Subcellular localization and sonodynamic damage.
- Author
-
Wang, Xinna, Luo, Jianmei, Leung, Albert Wingnang, Li, Yajun, Zhang, Hongwei, and Xu, Chuanshan
- Subjects
CANCER cells ,LIVER cancer ,MITOCHONDRIA ,TRANSMISSION electron microscopes ,ENDOPLASMIC reticulum - Abstract
Purpose: To study subcellular localization of hypocrellin B in hepatocellular carcinoma cells, and hypocrellin B-mediated sonodynamic action-induced cell damage. Materials and methods: After incubation with 2.5 μM of hypocrellin B, human hepatocellular carcinoma HepG2 cells were exposed to ultrasound waves for 8 sec at an intensity of 0.46 W/cm
2 . Clonogenic survival of HepG2 cells was measured using a colony forming assay and light microscope. Ultrastructural morphology was observed using transmission electron microscope (TEM) and mitochondrial membrane potential (MMP) was assessed using confocal laser scanning microcope (CLSM) after rhodamine 123 staining. Additionally, subcellular localization of hypocrellin B in HepG2 cells with organelle probe staining was also observed using CLSM. Results: The colony forming units of HepG2 cells decreased substantially after sonodynamic treatment. The results of TEM showed microvilli disappearance, apoptotic body formation, swollen mitochondria with loss of cristae and mitochondrial myelin-like features (or membrane whorls). Collapse of MMP was found in the treated cells. Hypocrellin B was distributed in mitochondria and lysosomes as well as in endoplasmic reticulum and Golgi apparatus. Conclusions: The findings demonstrated that sonodynamic action of hypocrellin B induced mitochondrial damage, survival inhibition, and apoptosis of HepG2 cells. Additionally, other subcellular organelles such as endoplasmic reticulum, Golgi apparatus and lysosomes were also the targets of hypocrellin B-mediated sonodynamic action as well as mitochondria. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
11. Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells.
- Author
-
Jiang, Yuan, Leung, Albert Wingnang, Wang, Xinna, Zhang, Hongwei, and Xu, Chuanshan
- Subjects
PHOTODYNAMIC therapy ,OVARIAN cancer ,CANCER cells ,APOPTOSIS ,CELL adhesion - Abstract
Purpose: In the present study, we investigated effects of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells in vitro. Materials and methods: Human ovarian cancer HO-8910 cell as a cancer model cell was incubated with hypocrellin B at a concentration of 2.5 μM for 5 h and irradiated by light from a light-emitting diodes (LED) source. Cell apoptosis was analyzed by flow cytometry with annexin V/propidium iodide (PI) staining and nuclear staining 6 h after hypocrellin B photoirradiation. Cell adhesion was assessed using the 3-(4, 5-dimthylthiazol-2-yl)-2, 5 diphenyl-tetrazolium bromide (MTT) assay 4 h after photodynamic treatment. Cell migration was measured 48 h after photodynamic treatment. Results: Flow cytometry with annexin V/PI staining showed that early apoptotic and late apoptotic (necrotic) rates following photodynamic therapy with hypocrellin B markedly increased to 16.40% and 24.67%, respectively. Nuclear staining found nuclear condensation and typical apoptotic body in the treated cells. The number of cell migration was significantly decreased to 183 ± 28 after photodynamic therapy with hypocrellin B ( p < 0.01). Light irradiation alone and hypocrellin B alone had no significant effect on cell migration. The cell adhesion inhibitory rate due to photodynamic action of hypocrellin B was 53.2 ± 1.8%, significantly higher than 2.7 ± 2.1% of light treatment alone and 1.0 ± 0.4% of hypocrellin B treatment alone ( p < 0.01). Conclusion: The findings demonstrated that photodynamic therapy with hypocrellin B remarkably induced apoptosis and inhibited adhesion and migration of cancer cells in vitro. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Photodynamic action of methylene blue in osteosarcoma cells in vitro.
- Author
-
Guan, Jiemin, Lai, Xiaoping, Wang, Xinna, Leung, Albert Wingnang, Zhang, Hongwei, and Xu, Chuanshan
- Abstract
Summary: Background: Osteosarcoma is a common malignant bone tumor which threatens the life of young people worldwide. To explore alternative strategy for combating osteosarcoma, a light-emitting diode (LED) that activates methylene blue (MB) was used in the present study to investigate cell death of osteosarcoma-derived UMR106 cells. Materials and methods: Photocytotoxicity in UMR106 cells was investigated 24h after photodynamic activation of MB using sulforhodamine B (SRB) assay and light microscopy. Apoptosis induction was observed 24h after photodynamic treatment using a confocal laser scanning microscopy (CLSM) with Hoechst 33342 staining. The change in mitochondrial membrane potential (MMP) was analyzed using a flow cytometry with rhodamine 123 staining. Results: MB under red light irradiation caused a drug-concentration (0–100μM) and light-dose (0–32J/cm
2 ) dependent cytotoxicity in UMR106 cells. The SRB assay and light microscopy observed a significant decrease in the number of UMR106 cells attached to the bottom of culture well after LED light-activated MB (100μM, 32J/cm2 ). Nuclear shrinkage, chromatin condensation and fragmentation were found in the treated cells by nuclear staining. In addition, flow cytometry showed that the MMP in UMR106 cells was rapidly reduced by photo-activated MB (100μM, 32J/cm2 ). Conclusion: Photodynamic action of MB under LED irradiation could remarkably kill osteosarcoma cells and induce cell apoptosis as well as MMP collapse. [Copyright &y& Elsevier]- Published
- 2014
- Full Text
- View/download PDF
13. Drug resistance-related miRNAs in hepatocellular cancer.
- Author
-
Hong, Liu, Han, Yu, Zhang, Hongwei, Zhao, Qingchuan, Wu, Kaichun, and Fan, Daiming
- Subjects
LIVER cancer ,CANCER chemotherapy ,DRUG resistance ,ONCOGENES ,TUMOR suppressor genes ,BIOMARKERS - Abstract
Hepatocellular cancer is a hypervascular cancer characterized by rapid progression as well as resistance to chemotherapy. Drug resistance arises from the alteration of many molecules, including oncogenes, tumor suppressor genes and miRNAs. This review evaluates the advances of drug resistance-related miRNAs in hepatocellular cancer, and analyzes the value of them as prognostic biomarkers and therapeutic targets. This review also discusses the limitations of miRNA-based therapy, and envisages future developments toward the clinical applications of drug resistance-related miRNAs. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Interleukin-24 Induces Neuroblastoma SH-SY5Y Cell Differentiation, Growth Inhibition, and Apoptosis by Promoting ROS Production.
- Author
-
Li, Yuan, Zhang, Hongwei, Zhu, Xiaoyu, Feng, Dongchuan, Gong, Jinchao, and Han, Tao
- Subjects
- *
NEUROBLASTOMA , *INTERLEUKINS , *APOPTOSIS , *CELL differentiation , *PROMOTERS (Genetics) , *REACTIVE oxygen species , *JUVENILE diseases , *PROGNOSIS - Abstract
Neuroblastoma is among the most aggressive tumors that occur in childhood and infancy. The clinical prognosis of children with advanced-stage neuroblastoma is still poor. Interleukin-24 (IL-24) is emerging as a new cytokine involved in tumor cellular proliferation, differentiation, and apoptosis and has been widely studied as a tumor inhibitor. However, little is known about this cytokine's role in neuroblastoma. In this study, we investigated the possible effects of IL-24 on inducing neuroblastoma cell differentiation, growth inhibition, and apoptosis in vitro. Our data show that IL-24 promotes neuroblastoma SH-SY5Y cell differentiation, growth inhibition, and apoptosis. Furthermore, we found that the differentiation- and apoptosis-inducing action of IL-24 depends on the accumulation of reactive oxygen species (ROS). These results suggest that IL-24 can induce neuroblastoma cell differentiation and apoptosis and may be a potential therapeutic agent for neuroblastoma. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol.
- Author
-
Li, Guanwu, He, Shunhua, Chang, Lijun, Lu, Hong, Zhang, Hongwei, Zhang, Hao, and Chiu, Jenfu
- Abstract
Abstract: Resveratrol (3,4′,5-trihydroxy-trans-stilbene), one of secondary metabolites of low molecular weight present in plant, has various important biological effects. It can induce apoptosis in human leukemia cell types in vitro, although the mechanism is not fully understood. In the present study, we demonstrated reduced viability and DNA synthesis, as well as increased proportion of the subdiploid cell population, in HL-60 cells as determined by cell cycle analysis with resveratrol. Resveratrol treatment resulted in a gradual time-dependent decrease in the expression of anti-apoptotic Bcl-2 and increase in that of Bax, annexin A1, growth arrest- and DNA damage-induced gene 45α (GADD45α), and cleaved caspase-3. In addition, resveratrol markedly increased caspase-3 activity in cells. Our results suggest that resveratrol could inhibit the proliferation and induce apoptosis of HL-60 cells through a GADD45α and annexin A1/caspase-3 pathway. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
16. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.
- Author
-
Hongwei Zhang, Mengbin Li, Yu Han, Liu Hong, Taiqian Gong, Li Sun, Xiushan Zheng, Zhang, Hongwei, Li, Mengbin, Han, Yu, Hong, Liu, Gong, Taiqian, Sun, Li, and Zheng, Xiushan
- Subjects
MULTIDRUG resistance ,APOPTOSIS ,ESOPHAGEAL cancer ,CANCER cells ,GENE transfection ,POLYMERASE chain reaction - Abstract
Background: So far, the miRNAs involved in multidrug resistance of esophageal cancer have not been reported.Aims and Methods: Here we have firstly investigated the roles of miR-27a in multidrug resistance of esophageal squamous cell carcinoma using MTT assay, flow cytometry assay, and reporter gene assay, etc.Results: Down-regulation of miR-27a could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-non-related drugs on esophageal cancer cells, and might promote ADR-induced apoptosis, accompanied by increased accumulation and decreased releasing amount of ADR. Down-regulation of miR-27a could significantly decrease the expression of P-glycoprotein, Bcl-2, and the transcription of the multidrug resistance gene 1, but up-regulate the expression of Bax.Conclusions: MiR-27a might play important roles in multidrug resistance of esophageal cancer. The further study of the biological functions of miR-27a might be helpful for developing possible strategies to treat esophageal cancer. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
17. Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl-2 pathway.
- Author
-
Zhang, Hongwei, Chi, Fenqing, Qin, Keru, Mu, Xiuli, Wang, Lieyang, Yang, Bin, Wang, Yanli, Bai, Min, Li, Zhenhua, Su, Liping, and Yu, Baofeng
- Subjects
- *
WESTERN immunoblotting , *HISTONE deacetylase inhibitors , *HISTONE deacetylase , *CELL death , *PHOSPHORYLATION , *CELL survival - Abstract
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant tumor type, and epigenetic modifications such as acetylation or deacetylation serve vital roles in its development. Chidamide, a novel histone deacetylase inhibitor, exerts an anticancer effect against various types of cancer. The present study aimed to evaluate the cellular effect of chidamide on a number of DLBCL cell lines and to investigate its underlying mechanism. The results demonstrated that chidamide induced the death of these cells in a concentration-(0–30 µmol/l) and time-dependent (24–72 h) manner, as determined using the Cell Counting Kit-8 cell viability assay. Moreover, chidamide promoted cellular apoptosis, which was identified via flow cytometry and western blot analysis, with an increase in cleaved caspase-3 expression and a decrease in Bcl-2 expression. Chidamide treatment also decreased the expression level of STAT3 and its phosphorylation, which was accompanied by the downregulation of a class-I histone deacetylase (HDAC) inhibitor, chidamide. Collectively, these data suggested that chidamide can be a potent therapeutic agent to treat DLBCL by inducing the apoptotic death of DLBCL cells by inhibiting the HDACs/STAT3/Bcl-2 pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Trans sodium crocetinate alleviates ischemia/reperfusion-induced myocardial oxidative stress and apoptosis via the SIRT3/FOXO3a/SOD2 signaling pathway.
- Author
-
Chang, Guodong, Chen, Yingwei, Zhang, Hongwei, and Zhou, Wen
- Subjects
- *
MYOCARDIAL reperfusion , *OXIDATIVE stress , *BCL-2 proteins , *BAX protein , *SODIUM , *APOPTOSIS - Abstract
Trans sodium crocetinate (TSC) has been reported to exert a protective effect against cerebral ischemia/reperfusion (I/R) injury. However, whether TSC protects against myocardial ischemia/reperfusion (MI/R) injury remains unknown. Herein, we found that TSC treatment reduced myocardial infract size and elevated serum LDH and CK activities of MI/R rats. TSC administration attenuated oxidative stress in MI/R rats and H9C2 cells exposed to oxygen glucose deprivation/reperfusion (OGD/R). TSC administration relieved I/R-induced myocardial apoptosis in vivo and in vitro , as evidenced by reduced number of TUNEL positive cells, accompanying with marked decreases in caspase-3 activity and Bax protein level and an increase in Bcl-2 protein level. TSC treatment markedly increased SIRT3 activity and SIRT3 and SOD2 protein levels, and could also diminished the phosphorylation of FOXO3a protein. Additionally, TSC treatment attenuated the acetylation of FOXO3a and SOD2 protein. But, these effects were obviously blocked by SIRT3 knockdown. Besides, SIRT3 knockdown blocked the cardioprotective effect of TSC on OGD/R-induced oxidative stress, apoptosis and mitochondrial dysfunction in vitro. In summary, TSC alleviates I/R-induced myocardial oxidative stress and apoptosis via the SIRT3/FOXO3a/SOD2 signaling pathway. Our study suggests that TSC may become a novel drug for the treatment of MI/R injury. • Trans sodium crocetinate (TSC) treatment alleviated MI/R injury. • TSC administration attenuated cell injury in vivo and in vitro. • SIRT3 knockdown blocked the cardioprotective effects of TSC. • TSC alleviates I/R-induced cell injury via the SIRT3/FOXO3a/SOD2 signaling. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells.
- Author
-
Xia, Peng, Liu, Pan, Fu, Qiang, Liu, Chuanjiang, Luo, Qiankun, Zhang, Xu, Cheng, Liyou, Qin, Tao, and Zhang, Hongwei
- Subjects
- *
NON-coding RNA , *CELL cycle , *CANCER cell growth , *CELL growth , *PANCREATIC cancer - Abstract
Pancreatic cancer (PC) is a fatal disease; most patients are asymptomatic before the disease enters the advanced stage, but molecular mechanisms of early PC that can be exploited for diagnosis are not clear. Long noncoding RNAs (lncRNAs) play key roles in the progression of PC. In this study, we found that the expression of the lncRNA EPIC1 (Lnc-EPIC1) is high in PC and closely related to tumor size, TNM staging and lymph node metastasis status. Silencing Lnc-EPIC1 by siRNA targeting could significantly inhibit the cell growth and colony formation ability of PC cells and induced G1/S cell cycle arrest and apoptosis in PC cells. Lnc-EPIC1-specific siRNAs could downregulate the expression of cyclins and CDKs, such as CDC20, CDK4 and Cyclin A1. Knocking out YAP1 with the CRISPR/Cas-9 gene editing method recapitulated the effects of the Lnc-EPIC1-specific siRNAs on cell growth, colony formation ability and apoptosis in PC cells. In addition, the Lnc-EPIC1-specific siRNAs did not further inhibit cell growth or promote apoptosis in YAP1-knockout (YAP1-KO) cells. RNA immunoprecipitation (RIP) results showed that there was a direct interaction between Lnc-EPIC1 and YAP1. An Lnc-EPIC1-overexpressing lentiviral vector promoted the growth of PC cells. The results show that Lnc-EPIC1 interacts with YAP1 to promote the progression of PC. Image 1 • Lnc-EPIC1 and YAP1 is highly expressed in pancreatic cancer. • Lnc-EPIC1 may promote tumor progression by promoting cell growth and reducing apoptosis. • Lnc-EPIC1 regulates PC progression by targeting YAP1, which impacts the downstream molecules CDC20, CDK4 and Cyclin A1. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Shape-dependent toxicity of alumina nanoparticles in rat astrocytes.
- Author
-
Dong, Li, Tang, Song, Deng, Fuchang, Gong, Yufeng, Zhao, Kangfeng, Zhou, Jianjun, Liang, Donghai, Fang, Jianlong, Hecker, Markus, Giesy, John P., Bai, Xuetao, and Zhang, Hongwei
- Abstract
Nanosized alumina (Al 2 O 3 -NPs), a widely used nanoparticle in numerous commercial applications, is released into environment posing a threat to the health of wildlife and humans. Recent research has revealed essential roles of physicochemical properties of nanoparticles in determining their toxicity potencies. However, influence of shape on neurotoxicity induced by heterogeneous Al 2 O 3 -NPs remains unknown. We herein compared the neurotoxicity of two shapes of γ-Al 2 O 3 -NPs (flake versus rod) and their effects on metabolic profiles of astrocytes in rat cerebral cortex. While exposed to both shapes caused significant cytotoxicity and apoptosis in a dose-dependent manner after 72 h exposure, a significantly stronger response was observed for nanorods than for nanoflakes. These effects were associated with significantly greater ROS accumulation and inflammation induction, as indicated by increased concentrations of IL-1β, IL-2 and IL-6. Using untargeted metabolomics, significant alternations in metabolism of amino acids, lipids and purines, and pyrimidines were observed after exposure to both types. Moreover, changes in the metabolome caused by nanorods were significantly greater than those by nanoflakes as also indicated by physiological stress responses to ROS, inflammation, and apoptosis. Taken together, these findings demonstrated the critical role of morphology in determining toxic potencies of nano-alumina and its underlying mechanisms of toxic actions. Unlabelled Image • γ-Al 2 O 3 -NPs significantly affected survivability and functioning of rat ASTs. • The shape of nanoparticles represents a significant factor in determining the potency and magnitude of effect. • Different toxicities were correlated with differential ROS accumulation, inflammatory responses and metabolic pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. Caspase 3 may participate in the anti-tumor immunity of dendritic cells.
- Author
-
Liu, Jinqiang, Wang, Fei, Yin, Dandan, Zhang, Hongwei, and Feng, Fan
- Subjects
- *
CASPASES , *DENDRITIC cells , *APOPTOSIS , *LYMPHOCYTES , *PHAGOCYTOSIS - Abstract
Abstract Background Caspase 3 is not only involved in apoptosis, but also participates in the nonapoptotic functions. Previously, we found that caspase 3 gene knockout mice displayed decreased number of dendritic cells (DCs). However, whether caspase 3 participate in the function of DCs is unclear. Thus, the present study aims to investigate the role of caspase 3 in the maturation and antitumor function of DCs. Methods Caspase 3 gene was overexpressed in DC2.4 cell line through Lentivirus system. The impact of caspase 3 gene overexpression on the biological behavior of DC2.4 cells was determined by CCK-8, colony formation and apoptosis analysis. The impact of caspase 3 gene overexpression on the antigen uptake, maturation, migration, T cell activation of DC2.4 cells was analyzed with phagocytosis, transwell and mixed lymphocyte reaction assay. Tumor growth and tumor infiltrated T cells were also investigated through tumor bearing model. Results Caspase 3 gene overexpression could slightly increase the apoptosis of DC2.4 cells. Antigen uptake capability and maturation of DC2.4 cells were significantly promoted through caspases 3 gene overexpression. However, CXCR4 expression on DC2.4 cells and migration of DC2.4 cells were not influenced. Caspase 3 gene overexpression also enhanced the T cell activation and cytotoxicity of activated T cells. Finally, overexpression of caspase 3 gene significantly increased the tumor suppression of DC2.4 cells, accompanied by increased infiltration of CD4+ and CD8+ Cells in tumor tissue. Conclusion Caspase 3 gene overexpression could promote maturation and enhance antitumor capability of DC2.4 cells. Highlights • Caspase 3 overexpression only slightly influenced apoptosis of DC2.4 cells. • Antigen uptake, maturation and T cell activation of DC2.4 cells were enhanced. • Finally, antitumor immunity of DC2.4 cells were enhanced. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2.
- Author
-
Lv, Chao, Huang, Yun, Wang, Qun, Wang, Chengji, Hu, Hongmei, Zhang, Hongwei, Lu, Dong, Jiang, Honghong, Shen, Ruling, Zhang, Weidong, and Liu, Sanhong
- Subjects
- *
COLORECTAL cancer , *CANCER cells , *CELL respiration , *APOPTOSIS , *TUMOR growth , *OXIDATIVE stress , *DRUG target - Abstract
The peroxiredoxin (PRDX) family is a class of antioxidant enzymes with peroxidase activity. Human PRDXs currently have six members (PRDX1–6), which are gradually becoming potential therapeutic targets for major diseases such as cancer. In this study, we reported ainsliadimer A (AIN), a sesquiterpene lactone dimer with antitumor activity. We found that AIN directly targets Cys173 of PRDX1 and Cys172 of PRDX2 and then inhibits their peroxidase activities. As a result, the level of intracellular ROS increases, causing oxidative stress damage in mitochondria, inhibiting mitochondrial respiration, and significantly inhibiting ATP production. AIN inhibits the proliferation and induces apoptosis of colorectal cancer cells. Additionally, it inhibits tumor growth in mice and the growth of tumor organoid models. Therefore, AIN can be one of the natural compounds targeting PRDX1 and PRDX2 in the treatment of colorectal cancer. [Display omitted] • PRDX1/2 are the targets of AIN • AIN directly binds to Cys173 of PRDX1 and Cys172 of PRDX2 • AIN induces ROS-mediated apoptosis in colorectal cancer cells • AIN increases ROS and inhibits mitochondrial respiration in colorectal cancer cells Lv et al. find that AIN covalently binds to Cys173 of PRDX1 and Cys172 of PRDX2 and then inhibits their enzymatic activities, which induces ROS-mediated apoptosis in colorectal cancer cells. AIN can be one of the natural compounds targeting PRDX1 and PRDX2 in the treatment of colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Remdesivir inhibits the progression of glioblastoma by enhancing endoplasmic reticulum stress.
- Author
-
Chen, Yujia, Guo, Yuduo, Li, Shenglun, Xu, Jiacheng, Ning, Weihai, Zhao, Chao, Wang, Jun, Qu, Yanming, Zhang, Mingshan, Zhou, Wanlu, Cui, Qinghua, and Zhang, Hongwei
- Subjects
- *
ENDOPLASMIC reticulum , *UNFOLDED protein response , *REMDESIVIR , *METHYLGUANINE , *BRAIN tumors , *GLIOBLASTOMA multiforme - Abstract
Glioblastoma (GBM) is one of the most aggressive primary malignant brain tumors. The major challenge is the lack of effective therapeutic drugs due to the blood–brain barrier (BBB) and tumor heterogeneity. Remdesivir (RDV), a new member of the nucleotide analog family, has previously been shown to have excellent antiviral effects and BBB penetration, and was predicted here to have anti-GBM effects. In vitro experiments, RDV significantly inhibited the growth of GBM cells, with IC 50 values markedly lower than those of normal cell lines or the same cell lines treated with temozolomide. Moreover, in multiple mouse models, RDV not only distinctly inhibited the progression and improved the prognosis of GBM but also exhibited a promising biosafety profile, as manifested by the lack of significant body weight loss, liver or kidney dysfunction or organ structural damage after administration. Furthermore, we investigated the anti-GBM mechanism by RNA-seq and identified that RDV might induce apoptosis of GBM cells by enhancing endoplasmic reticulum (ER) stress and activating the PERK-mediated unfolded protein response. In conclusion, our results indicated that RDV might serve as a novel agent for GBM treatment by increasing ER stress and inducing apoptosis in GBM cells. [Display omitted] • Remdesivir, a novel antiviral drug, was predicted to have antitumor effects. • Remdesivir inhibited the growth of glioma cells both in vitro and in vivo. • Remdesivir prolonged survival of glioma-bearing mice. • Endoplasmic reticulum stress is responsible for glioma inhibition in remdesivir. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
- Author
-
Han, Yifang, Cai, Hui, Ma, Liye, Ding, Yibo, Tan, Xiaojie, Liu, Yan, Su, Tong, Yu, Yongwei, Chang, Wenjun, Zhang, Hongwei, Fu, Chuangang, and Cao, Guangwen
- Subjects
- *
CANCER chemotherapy , *COLON tumors , *PROBABILITY theory , *SURVIVAL analysis (Biometry) , *PROPORTIONAL hazards models , *DESCRIPTIVE statistics , *PROGNOSIS ,RECTUM tumors - Abstract
Abstract: Background: NR4A2, an orphan nuclear receptor essential in neuron generation, has been recently linked to inflammatory and metabolic pathways of colorectal carcinoma (CRC). However, the effects of NR4A2 on chemo-resistance and postoperative prognosis of CRC remain unknown. Methods: NR4A2 was transfected into CRC cells to investigate its effects on chemo-resistance to 5-fluorouracil and oxaliplatin and chemotherapeutics-induced apoptosis. We also investigated prostaglandin E2 (PGE2)-induced NR4A2 expression and its effect on chemo-resistance. Tissue microarrays including 51 adenoma, 14 familial adenomatous polyposis with CRC, 17 stage IV CRC with adjacent mucosa and 682 stage I–III CRC specimens were examined immunohistochemically for NR4A2 expression. Median follow-up time for stage I–III CRC patients was 53months. Results: Ectopic expression of NR4A2 increased the chemo-resistance, and attenuated the chemotherapeutics-induced apoptosis. Transient treatment of PGE2 significantly up-regulated NR4A2 expression via protein kinase A pathway and increased the chemo-resistance. NR4A2 expression in epithelials consecutively increased from adenoma, adjacent mucosa to CRC (P trend <0.001). In multivariate Cox regression analyses, high NR4A2 expression in cancer nuclei (immunoreactive score⩾4) significantly predicted a shorter disease-specific survival (DSS) of CRC patients (hazard ratio [HR]=1.88, P =0.024). High NR4A2 expression specifically predicted a shorter DSS of colon cancer patients (dichotomisation, HR=2.55, log-rank test P =0.011), especially for those who received postoperative 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) chemotherapy (3-score range, HR=1.86, log-rank test P =0.020). Conclusion: High expression of NR4A2 in CRC cells confers chemo-resistance, attenuates chemotherapeutics-induced apoptosis, and predicts unfavorable prognosis of colon cancer patients, especially for those who received postoperative chemotherapy. NR4A2 may be prognostic and predictive for colon cancer. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
25. CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis
- Author
-
Han, Xiaodong, Wu, Zhenqian, Di, Jianzhong, Pan, Ye, Zhang, Hongwei, Du, Yibao, Cheng, Zhe, Jin, Zhiming, Wang, Zhigang, Zheng, Qi, Zhang, Pin, and Wang, Yu
- Subjects
- *
CANCER chemotherapy , *FLUOROURACIL , *GENE expression , *CANCER cell proliferation , *CARCINOGENESIS , *ANTINEOPLASTIC agents - Abstract
Abstract: Mucositis arising from cancer chemotherapy is a common problem for which there is no definitive treatment. 5-fluorouracil (5-FU) is a common cytotoxic agent used to treat solid tumors. A global gene expression array was performed to identify genetic signals involved in the pathogenesis of mucositis. The chemokine (C-X-C motif) ligand 9 (CXCL9) was one of the candidates identified that presented a characteristic gene expression profile; its temporal expression pattern was correlated with the damage and regeneration phases of the small intestine upon 5-FU chemotherapy. We found that prophylactic CXCL9 administration was able to attenuate the severity of mucositis, weight loss and diarrhea caused by chemotherapy. CXCL9 also increased the tolerance of the mice to lethal-dose chemotherapy. Moreover, we demonstrated that CXCL9 was able to promote the proliferation and regeneration of intestinal cells by inhibiting the proliferation of normal intestinal mucosal cells prior to chemotherapy and by reducing the 5-FU-induced apoptosis in intestinal crypts. Thus, pretreatment with CXCL9 is a new and promising strategy for the alleviation of chemotherapy-induced intestinal mucositis in clinical settings. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.